"Atrium Health Levine Cancer Institute provides access to top-ranked physician expertise, groundbreaking clinical trials and the latest cancer treatments across the Carolinas."

During the past decade, Carolinas Medical Center/Levine Cancer Institute conducted 329 clinical trials. In the 10-year time frame, 329 clinical trials started and 178 clinical trials were completed, i.e. on average, 54.1% percent of trials that started reached the finish line to date. In the past 5 years, 108 clinical trials started and 85 clinical trials were completed. i.e. 78.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carolinas Medical Center/Levine Cancer Institute" #1 sponsor was "National Cancer Institute (NCI)" with 113 trials, followed by "Children's Oncology Group" with 60 trials sponsored, "Wake Forest University Health Sciences" with 40 trials sponsored, "Janssen Research & Development, LLC" with 26 trials sponsored and "Hoffmann-La Roche" with 26 trials sponsored. Other sponsors include 246 different institutions and companies that sponsored additional 112 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carolinas Medical Center/Levine Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 132 trials as a collaborator, "NRG Oncology" with 33 trials as a collaborator, "Atrium Health Levine Cancer Institute" with 11 trials as a collaborator, "Bristol-Myers Squibb" with 10 trials as a collaborator and "Merck Sharp & Dohme LLC" with 9 trials as a collaborator. Other collaborators include 190 different institutions and companies that were collaborators in the rest 117 trials.

According to Clinical.Site data, the most researched conditions in "Carolinas Medical Center/Levine Cancer Institute" are "Multiple Myeloma" (41 trials), "Recurrent Neuroblastoma" (20 trials), "Recurrent Osteosarcoma" (16 trials), "Refractory Neuroblastoma" (15 trials) and "Refractory Non-Hodgkin Lymphoma" (14 trials). Many other conditions were trialed in "Carolinas Medical Center/Levine Cancer Institute" in a lesser frequency.

Most popular intervention types in "Carolinas Medical Center/Levine Cancer Institute" are "Drug" (409 trials), "Other" (192 trials), "Biological" (131 trials), "Procedure" (79 trials) and "Radiation" (74 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (115 trials), "Quality-of-Life Assessment" (60 trials), "Cyclophosphamide" (57 trials), "Carboplatin" (54 trials) and "Dexamethasone" (42 trials). Other intervention names were less common.

The vast majority of trials in "Carolinas Medical Center/Levine Cancer Institute" are 426 trials for "All" genders, 77 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are 323 active trials in "Carolinas Medical Center/Levine Cancer Institute". 2 are not yet recruiting, 149 are recruiting, 170 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 151 completed trials in Carolinas Medical Center/Levine Cancer Institute, 6 suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Carolinas Medical Center/Levine Cancer Institute, 98 "Phase 1" clinical trials were conducted, 234 "Phase 2" clinical trials and 178 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 21 trials that are defined as “Not Applicable".